Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2017 Dec 8;17(1):213.
doi: 10.1186/s12883-017-0985-0.

Inventory of real world data sources in Parkinson's disease

Audrey Tanguy  1 , Linus Jönsson  1 , Lianna Ishihara  2
Affiliations
Review

Inventory of real world data sources in Parkinson's disease

Audrey Tanguy et al. BMC Neurol. .

Abstract

Background: Real world data have an important role to play in the evaluation of epidemiology and burden of disease; and in assisting health-care decision-makers, especially related to coverage and payment decisions. However, there is currently no overview of the existing longitudinal real world data sources in Parkinson's disease (PD) in the USA. Such an assessment can be very helpful, to support a future effort to harmonize real world data collection and use the available resources in an optimal way.

Methods: The objective of this comprehensive literature review is to systematically identify and describe the longitudinal, real world data sources in PD in the USA, and to provide a summary of their measurements (categorized into 8 main dimensions: motor and neurological functions, cognition, psychiatry, activities of daily living, sleep, quality of life, autonomic symptoms and other). The literature search was performed using MEDLINE, EMBASE and internet key word search.

Results: Of the 53 data sources identified between May and August 2016, 16 were still ongoing. Current medications (81%) and comorbidities (79%) were frequently collected, in comparison to medical imaging (36%), genetic information (30%), caregiver burden (11%) and healthcare costs (2%). Many different measurements (n = 108) were performed and an interesting variability among used measurements was revealed.

Conclusions: Many longitudinal real world data sources on PD exist. Different types of measurements have been performed over time. To allow comparison and pooling of these multiple data sources, it will be essential to harmonize practices in terms of types of measurements.

Keywords: Cohort studies; Longitudinal; Parkinson disease; Rating scales; Real-world.

PubMed Disclaimer

Conflict of interest statement

Ethics approval and consent to participate

Not applicable.

Consent for publication

Not applicable.

Competing interests

LJ is a current employee and AT was a resident in Lundbeck SAS and LI was an employee of Lundbeck SAS at the time the research was carried out.

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Figures

Fig. 1
Fig. 1
Flowchart
See this image and copyright information in PMC

References

    1. Kowal SL, Dall TM, Chakrabarti R, Storm MV, Jain A. The current and projected economic burden of Parkinson’s disease in the United States. Mov Disord. 2013;28:311–318. doi: 10.1002/mds.25292. - DOI - PubMed
    1. Use of Real-World Evidence to Support Regulatory Decision-Making for Medical Devices: FDA Draft Guidance for Industry and Staff. Food Drug Administration. http://www.fda.gov/ucm/groups/fdagov-public/@fdagov-meddev-gen/documents.... Accessed 29 Nov 2017.
    1. Bot BM, Suver C, Neto EC, et al. The mPower study, Parkinson disease mobile data collected using ResearchKit. Scientific Data. 2016;3:160011. doi: 10.1038/sdata.2016.11. - DOI - PMC - PubMed
    1. Lerche S, Liepelt-Scarfone I, Alves G, et al. Methods in Neuroepidemiology characterization of European longitudinal cohort studies in Parkinson’s disease – report of the JPND working group BioLoc-PD. Neuroepidemiology. 2015;45:282–297. doi: 10.1159/000439221. - DOI - PubMed
    1. Mahajan R. Real world data: additional source for making clinical decisions. Int J Appl Basic Med Res. 2015; doi:10.4103/2229-516X.157148. - PMC - PubMed